Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Early research (Phase 1)Ended earlyNCT03957096What this trial is testingA Safety Study of SGN-CD47M in Patients With Solid TumorsWho this might be right forSoft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more Seagen Inc. 16
Large-scale testing (Phase 3)Ended earlyNCT00227617What this trial is testingCombination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more University of California, San Francisco 36
Large-scale testing (Phase 3)Study completedNCT00325104What this trial is testingCinacalcet to Treat Familial Primary HyperparathyroidismWho this might be right forHypercalcemiaFamilial Primary Hyperparathyroidism National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Not applicableLooking for participantsNCT06605404What this trial is testingPan-tumor MRD StudyWho this might be right forMuscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more Paradigm Health 1,350
Early research (Phase 1)Study completedNCT01131234What this trial is testingGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03891784What this trial is testingAbemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine TumorsWho this might be right forAdvanced Digestive System Neuroendocrine NeoplasmDigestive System Neuroendocrine TumorForegut Neuroendocrine Tumor+6 more University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT02651987What this trial is testingEfficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mgWho this might be right forPancreatic TumoursMidgut Neuroendocrine Tumours Ipsen 99
Not applicableStudy completedNCT06080204What this trial is testingReal-world Study on Adjuvant Octreotide Therapy in pNETsWho this might be right forPancreatic Neuroendocrine Tumor G2 Changhai Hospital 411
Not applicableNo Longer AvailableNCT03554434What this trial is testingAn Expanded Access Program for AM0010 (Pegilodecakin)Who this might be right forMelanomaProstate CancerOvarian Cancer+6 more Eli Lilly and Company
Early research (Phase 1)Ended earlyNCT06270082What this trial is testingStudy of IK-595 in RAS- or RAF-altered Advanced TumorsWho this might be right forSolid Tumor, AdultColorectal CancerPancreatic Cancer+7 more Ikena Oncology 75
Not applicableStudy completedNCT00974610What this trial is testingStudy of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.Who this might be right forBreast CancerColorectal CancerLung Cancer+2 more Cancer Trials Ireland 803
Not applicableUnknownNCT03884179What this trial is testingDiagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of AccuracyWho this might be right forPancreatic CystPancreatic Neuroendocrine CarcinomaPancreatic Pseudocyst+5 more Sahlgrenska University Hospital 58
Early research (Phase 1)Study completedNCT04148937What this trial is testingThe CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 52
Not applicableActive Not RecruitingNCT07796594What this trial is testingIntegration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in CancerWho this might be right forMelanomaPancreas Cancer Amsterdam UMC, location VUmc 180
Not applicableStudy completedNCT05565066What this trial is testingA Real-world Comparison of FNB and FNA in IHC-required Lesions.Who this might be right forNeuroendocrine TumorsAutoimmune PancreatitisGastrointestinal Stromal Tumors Huazhong University of Science and Technology 439
Large-scale testing (Phase 3)Looking for participantsNCT05884255What this trial is testingAn Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.Who this might be right forAdvanced Gastroenteropancreatic Neuroendocrine Tumor Jiangsu HengRui Medicine Co., Ltd. 220
Early research (Phase 1)Study completedNCT01204476What this trial is testingCixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaWho this might be right forGastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more National Cancer Institute (NCI) 27
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc